Kristy Crooks

ORCID: 0000-0001-8263-096X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • BRCA gene mutations in cancer
  • Cancer Genomics and Diagnostics
  • Genomic variations and chromosomal abnormalities
  • SARS-CoV-2 and COVID-19 Research
  • Genetic Associations and Epidemiology
  • Glaucoma and retinal disorders
  • Pharmacogenetics and Drug Metabolism
  • Thyroid Cancer Diagnosis and Treatment
  • Retinal Diseases and Treatments
  • Ethics in Clinical Research
  • Epigenetics and DNA Methylation
  • Genetic factors in colorectal cancer
  • Neurogenetic and Muscular Disorders Research
  • Prenatal Screening and Diagnostics
  • Renal and related cancers
  • Ophthalmology and Eye Disorders
  • Race, Genetics, and Society
  • interferon and immune responses
  • Metabolism and Genetic Disorders
  • Immune responses and vaccinations
  • COVID-19 Clinical Research Studies
  • Proteoglycans and glycosaminoglycans research
  • Bioinformatics and Genomic Networks
  • Health Systems, Economic Evaluations, Quality of Life

University of Colorado Anschutz Medical Campus
2016-2025

Hunter New England Local Health District
2025

University of Colorado Denver
2017-2024

Duke University
2010-2018

University of North Carolina at Chapel Hill
2014-2018

Renaissance Computing Institute
2018

The Ohio State University Wexner Medical Center
2018

Oregon Health & Science University
2018

Duke University Hospital
2009-2014

Duke Medical Center
2009-2014

Recommendations for laboratories to report incidental findings from genomic tests have stimulated interest in such results. In order investigate the criteria and processes assigning pathogenicity of specific variants estimate frequency patients European African ancestry, we classified potentially actionable pathogenic single-nucleotide (SNVs) all 4300 European- 2203 African-ancestry participants sequenced by NHLBI Exome Sequencing Project (ESP). We considered 112 gene-disease pairs selected...

10.1101/gr.183483.114 article EN cc-by-nc Genome Research 2015-01-30
Wei Zhou Masahiro Kanai Kuan-Han Wu Humaira Rasheed Kristin Tsuo and 95 more Jibril Hirbo Ying Wang Arjun Bhattacharya Huiling Zhao Shinichi Namba Ida Surakka Brooke N. Wolford Valeria Lo Faro Esteban A. Lopera-Maya Kristi Läll Marie-Julie Favé Juulia Partanen Sinéad B. Chapman Juha Karjalainen Mitja Kurki Mutaamba Maasha Ben Brumpton Sameer Chavan Tzu‐Ting Chen Michelle Daya Yi Ding Yen‐Chen Anne Feng Lindsay Guare Christopher R. Gignoux Sarah E. Graham Whitney Hornsby Nathan Ingold Said I. Ismail Ruth Johnson Triin Laisk Kuang Lin Jun Lv Iona Y. Millwood Sonia Moreno‐Grau Kisung Nam Priit Palta Anita Pandit Michael Preuß Chadi Saad Shefali Setia-Verma Unnur Þorsteinsdóttir Jasmina Uzunović Anurag Verma Matthew Zawistowski Xue Zhong Nahla Afifi Kawthar Al-Dabhani Asma Al Thani Yuki Bradford Archie Campbell Kristy Crooks Geertruida H. de Bock Scott M. Damrauer Nicholas J. Douville Sarah Finer Lars G. Fritsche Eleni Fthenou Gilberto Gonzalez-Arroyo Chris Griffiths Yu Guo Karen A. Hunt Alexander Ioannidis Nomdo M. Jansonius Takahiro Konuma Ming Ta Michael Lee Arturo Lopez-Pineda Yuta Matsuda Riccardo E. Marioni Babak Moatamed Marco A. Nava-Aguilar Kensuke Numakura Snehal Patil Nicholas Rafaels Anne Richmond Agustin Rojas‐Muñoz Jonathan Shortt Péter Straub Ran Tao Brett Vanderwerff Manvi Vernekar Yogasudha Veturi Kathleen C. Barnes Marike Boezen Zhengming Chen Chia‐Yen Chen Judy H. Cho George Davey Smith Hilary K. Finucane Lude Franke Eric R. Gamazon Andrea Ganna Tom R. Gaunt Tian Ge Hailiang Huang Jennifer E. Huffman

10.1016/j.xgen.2022.100192 article EN Cell Genomics 2022-10-01
Ying Wang Shinichi Namba Esteban A. Lopera-Maya Sini Kerminen Kristin Tsuo and 95 more Kristi Läll Masahiro Kanai Wei Zhou Kuan-Han Wu Marie-Julie Favé Laxmi Bhatta Philip Awadalla Ben Brumpton Patrick Deelen Kristian Hveem Valeria Lo Faro Reedik Mägi Yoshinori Murakami Serena Sanna Jordan W. Smoller Jasmina Uzunović Brooke N. Wolford Cristen J. Willer Eric R. Gamazon Nancy J. Cox Ida Surakka Yukinori Okada Alicia R. Martin Jibril Hirbo Wei Zhou Masahiro Kanai Kuan-Han Wu Humaira Rasheed Kristin Tsuo Jibril Hirbo Ying Wang Arjun Bhattacharya Huiling Zhao Shinichi Namba Ida Surakka Brooke N. Wolford Valeria Lo Faro Esteban A. Lopera-Maya Kristi Läll Marie-Julie Favé Sinéad B. Chapman Juha Karjalainen Mitja Kurki Mutaamba Maasha Juulia Partanen Ben Brumpton Sameer Chavan Tzu‐Ting Chen Michelle Daya Yi Ding Yen‐Chen Anne Feng Christopher R. Gignoux Sarah E. Graham Whitney Hornsby Nathan Ingold Ruth Johnson Triin Laisk Kuang Lin Jun Lv Iona Y. Millwood Priit Palta Anita Pandit Michael Preuß Unnur Þorsteinsdóttir Jasmina Uzunović Matthew Zawistowski Xue Zhong Archie Campbell Kristy Crooks Geertruida H. de Bock Nicholas J. Douville Sarah Finer Lars G. Fritsche Chris Griffiths Yu Guo Karen A. Hunt Takahiro Konuma Riccardo E. Marioni Jansonius Nomdo Snehal Patil Nicholas Rafaels Anne Richmond Jonathan Shortt Péter Straub Ran Tao Brett Vanderwerff Kathleen C. Barnes Marike Boezen Zhengming Chen Chia‐Yen Chen Judy H. Cho George Davey Smith Hilary K. Finucane Lude Franke Eric R. Gamazon

Polygenic risk scores (PRSs) have been widely explored in precision medicine. However, few studies thoroughly investigated their best practices global populations across different diseases. We here utilized data from Global Biobank Meta-analysis Initiative (GBMI) to explore methodological considerations and PRS performance 9 biobanks for 14 disease endpoints. Specifically, we constructed PRSs using pruning thresholding (P + T) PRS-continuous shrinkage (CS). For both methods, a European-based...

10.1016/j.xgen.2022.100241 article EN cc-by-nc-nd Cell Genomics 2023-01-01

Precision medicine initiatives across the globe have led to a revolution of repositories linking large-scale genomic data with electronic health records, enabling analyses entire phenome. Many these focus solely on research insights, leading limited direct benefit patients. We describe biobank at Colorado Center for Personalized Medicine (CCPM Biobank) that was jointly developed by University Anschutz Medical Campus and UCHealth serve as unique, dual-purpose clinical resource accelerating...

10.1016/j.ajhg.2023.12.001 article EN cc-by-nc-nd The American Journal of Human Genetics 2024-01-01

The Clinical Genome Resource (ClinGen) Ancestry and Diversity Working Group highlights the need to develop guidance on race, ethnicity, ancestry (REA) data collection use in clinical genomics. We present quantitative qualitative evidence characterize: (1) acquisition of REA via laboratory requisition forms, (2) information disparity across populations Aggregation Database (gnomAD) at clinically relevant sites ascertained from annotations ClinVar. Our form analysis showed substantial...

10.1002/humu.23644 article EN Human Mutation 2018-10-11

Genetics researchers and clinical professionals rely on diversity measures such as race, ethnicity, ancestry (REA) to stratify study participants patients for a variety of applications in research precision medicine. However, there are no comprehensive, widely accepted standards or guidelines collecting using data genetics practice. Two NIH-funded consortia, the Clinical Genome Resource (ClinGen) Sequencing Evidence-generating Research (CSER), have partnered address this issue report how REA...

10.1016/j.ajhg.2020.05.005 article EN cc-by-nc-nd The American Journal of Human Genetics 2020-06-06

Since the onset of SARS-CoV-2 pandemic, most clinical testing has focused on RT-PCR1. Host epigenome manipulation post coronavirus infection2-4 suggests that DNA methylation signatures may differentiate patients with infection from uninfected individuals, and help predict COVID-19 disease severity, even at initial presentation.We customized Illumina's Infinium MethylationEPIC array to enhance immune response detection profiled peripheral blood samples 164 longitudinal measurements severity...

10.1038/s43856-021-00042-y article EN cc-by Communications Medicine 2021-10-26
Masahiro Kanai Roy Elzur Wei Zhou Mark J. Daly Hilary K. Finucane and 95 more Wei Zhou Masahiro Kanai Kuan-Han Wu Humaira Rasheed Kristin Tsuo Jibril Hirbo Ying Wang Arjun Bhattacharya Huiling Zhao Shinichi Namba Ida Surakka Brooke N. Wolford Valeria Lo Faro Esteban A. Lopera-Maya Kristi Läll Marie-Julie Favé Juulia Partanen Sinéad B. Chapman Juha Karjalainen Mitja Kurki Mutaamba Maasha Ben Brumpton Sameer Chavan Tzu‐Ting Chen Michelle Daya Yi Ding Yen‐Chen Anne Feng Lindsay Guare Christopher R. Gignoux Sarah E. Graham Whitney Hornsby Nathan Ingold Said I. Ismail Ruth Johnson Triin Laisk Kuang Lin Jun Lv Iona Y. Millwood Sonia Moreno‐Grau Kisung Nam Priit Palta Anita Pandit Michael Preuß Chadi Saad Shefali Setia-Verma Unnur Þorsteinsdóttir Jasmina Uzunović Anurag Verma Matthew Zawistowski Xue Zhong Nahla Afifi Kawthar Al-Dabhani Asma Al Thani Yuki Bradford Archie Campbell Kristy Crooks Geertruida H. de Bock Scott M. Damrauer Nicholas J. Douville Sarah Finer Lars G. Fritsche Eleni Fthenou Gilberto Gonzalez-Arroyo Chris Griffiths Yu Guo Karen A. Hunt Alexander Ioannidis Nomdo M. Jansonius Takahiro Konuma Ming Ta Michael Lee Arturo Lopez-Pineda Yuta Matsuda Riccardo E. Marioni Babak Moatamed Marco A. Nava-Aguilar Kensuke Numakura Snehal Patil Nicholas Rafaels Anne Richmond Agustin Rojas‐Muñoz Jonathan Shortt Péter Straub Ran Tao Brett Vanderwerff Manvi Vernekar Yogasudha Veturi Kathleen C. Barnes Marike Boezen Zhengming Chen Chia‐Yen Chen Judy H. Cho George Davey Smith Hilary K. Finucane Lude Franke Eric R. Gamazon

10.1016/j.xgen.2022.100210 article EN Cell Genomics 2022-11-04

During limbic epileptogenesis in vivo the dentate granule cells (DGCs) exhibit increased expression of brain-derived neurotrophic factor (BDNF), followed by striking morphologic plasticities, namely formation basal dendrites and sprouting mossy fibers. We hypothesized that BDNF intrinsic to DGCs is sufficient induce these plasticities. To test this hypothesis, we transfected rat hippocampal slice cultures with or nerve growth (NGF) via particle-mediated gene transfer, visualized neuronal...

10.1523/jneurosci.22-22-09754.2002 article EN Journal of Neuroscience 2002-11-15

As genome-scale sequencing is increasingly applied in clinical scenarios, a wide variety of genomic findings will be discovered as secondary or incidental findings, and there debate about how they should handled. The actionability such varies, necessitating standardized frameworks for priori decision making their analysis.We established semiquantitative metric to assess five elements actionability: severity likelihood the disease outcome, efficacy burden intervention, knowledge base, with...

10.1038/gim.2015.104 article EN cc-by-nc-sa Genetics in Medicine 2015-08-13

As whole exome sequencing (WES) becomes more widely used in the clinical realm, a wealth of unanalyzed information will be routinely generated. Using WES read depth data to predict copy number variation (CNV) could extend diagnostic utility this previously underutilized by providing clinically important such as unsuspected deletions or duplications. We evaluated ExomeDepth, free R package, addition an aneuploidy prediction method, detect CNVs data. First, blinded pilot study, five out...

10.1371/journal.pone.0209185 article EN cc-by PLoS ONE 2018-12-17
Wei Zhou Masahiro Kanai Kuan-Han Wu Humaira Rasheed Kristin Tsuo and 95 more Jibril Hirbo Ying Wang Arjun Bhattacharya Huiling Zhao Shinichi Namba Ida Surakka Brooke N. Wolford Valeria Lo Faro Esteban A. Lopera-Maya Kristi Läll Marie-Julie Favé Sinéad B. Chapman Juha Karjalainen Mitja Kurki Mutaamba Maasha Ben Brumpton Sameer Chavan Tzu‐Ting Chen Michelle Daya Yi Ding Yen‐Chen Anne Feng Christopher R. Gignoux Sarah E. Graham Whitney Hornsby Nathan Ingold Ruth Johnson Triin Laisk Kuang Lin Jun Lv Iona Y. Millwood Priit Palta Anita Pandit Michael Preuß Unnur Þorsteinsdóttir Jasmina Uzunović Matthew Zawistowski Xue Zhong Archie Campbell Kristy Crooks Geertruida H. de Bock Nicholas J. Douville Sarah Finer Lars G. Fritsche Chris Griffiths Yu Guo Karen A. Hunt Takahiro Konuma Riccardo E. Marioni Jansonius Nomdo Snehal Patil Nicholas Rafaels Anne Richmond Jonathan Shortt Péter Straub Ran Tao Brett Vanderwerff Kathleen C. Barnes Marike Boezen Zhengming Chen Chia‐Yen Chen Judy H. Cho George Davey Smith Hilary K. Finucane Lude Franke Eric R. Gamazon Andrea Ganna Tom R. Gaunt Tian Ge Hailiang Huang Jennifer E. Huffman Clara Lajonchere Matthew H. Law Liming Li Cecilia M. Lindgren Ruth J. F. Loos Stuart MacGregor Koichi Matsuda Catherine M. Olsen David J. Porteous Jordan A. Shavit Harold Snieder Richard C. Trembath Judith M. Vonk David C. Whiteman Stephen J. Wicks Cisca Wijmenga John Wright Jie Zheng Xiang Zhou Philip Awadalla Michael Boehnke Nancy J. Cox Daniel H. Geschwind Caroline Hayward Kristian Hveem

Summary Biobanks are being established across the world to understand genetic, environmental, and epidemiological basis of human diseases with goal better prevention treatments. Genome-wide association studies (GWAS) have been very successful at mapping genomic loci for a wide range traits, but in general, lack appropriate representation diverse ancestries - most biobanks preceding GWAS composed individuals European ancestries. Here, we introduce Global Biobank Meta-analysis Initiative...

10.1101/2021.11.19.21266436 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2021-11-21

Abstract Purpose To describe our experiences implementing and iterating CYP2C19 genotype–guided clopidogrel pharmacogenetic clinical decision support (CDS) tools over time in the setting of a large health system–wide, preemptive pharmacogenomics program. Summary Clopidogrel-treated patients who are genetically predicted cytochrome P450 isozyme 2C19 (CYP2C19) intermediate or poor metabolizers have an increased risk atherothrombotic events, some which can be life-threatening. The Clinical...

10.1093/ajhp/zxae008 article EN American Journal of Health-System Pharmacy 2024-01-20

To evaluate the diagnostic yield and workflow of genome-scale sequencing in patients with neuromuscular disorders (NMDs).We performed exome 93 undiagnosed various NMDs for whom a molecular diagnosis was not yet established. Variants on both targeted broad gene lists were identified. Prior tests extracted from patient's medical record to use context their prior workup.The overall our cohort 12.9%, one or more pathogenic likely variants identified causative associated disorder. Targeted had...

10.1212/nxg.0000000000000212 article EN cc-by-nc-nd Neurology Genetics 2018-02-01

Drug-induced QT prolongation (diLQTS), and subsequent risk of torsade de pointes, is a major concern with use many medications, including for non-cardiac conditions. The possibility that genetic risk, in the form polygenic scores (PGS), could be integrated into prediction diLQTS has great potential, although it unknown how related to clinical factors as might applied decision-making. In this study, we examined PGS interval 2500 subjects exposed known QT-prolonging drug on over 500ms ECG...

10.1371/journal.pone.0303261 article EN cc-by PLoS ONE 2024-06-17

Little is known about how many insured patients receive pharmacogenetic testing. We describe trends of single-gene testing in a US managed care population, and demographic clinical characteristics who received test.We leveraged random sample nearly 11 million from data set paid medical pharmacy claims to identify with at least one claim indicating receipt these tests: CYP2C19, CYP2D6, CYP2C9, VKORC1, UGT1A1, HLA class 1 typing.From January 2013 30 September 2017, 5712 test (55% female; mean...

10.1038/s41436-020-0788-3 article EN cc-by-nc-nd Genetics in Medicine 2020-04-14

Abstract Context Thyroid nodule ultrasound-based risk stratification schemas rely on the presence of high-risk sonographic features. However, some malignant thyroid nodules have benign appearance ultrasound. New methods for assessment are needed. Objective We investigated polygenic score (PRS) accounting inherited cancer combined with analysis improved assessment. Methods The convolutional neural network classifier was trained ultrasound still images and cine clips from 621 nodules....

10.1210/clinem/dgad530 article EN other-oa The Journal of Clinical Endocrinology & Metabolism 2023-09-08

This study explored Aboriginal and Torres Strait Islander peoples’ experiences receiving cultural support from a public health unit in Hunter New England Local Health District South Wales. Using an Indigenist research approach, online survey was conducted as well yarning with people who had received while isolation during the COVID-19 pandemic. Non-Aboriginal parents carers of children were also eligible. Of 3,819 eligible individuals, 70 surveys 55 valid responses after excluding 15....

10.47389/40.2.52 article EN Australian Journal of Emergency Management 2025-04-01

Thyroid diseases are common and highly heritable. Under the Global Biobank Meta-analysis Initiative, we performed a meta-analysis of genome-wide association studies from 19 biobanks for five thyroid diseases: cancer, benign nodular goiter, Graves' disease, lymphocytic thyroiditis, primary hypothyroidism. We analyzed genetic data ~2.9 million genomes identified 235 known 501 novel independent variants significantly linked to diseases. discovered correlations between autoimmune (r2=0.21-0.97)....

10.1101/2025.05.15.25327513 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2025-05-16
Coming Soon ...